471 related articles for article (PubMed ID: 31480057)
1. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
Guu TW; Mischoulon D; Sarris J; Hibbeln J; McNamara RK; Hamazaki K; Freeman MP; Maes M; Matsuoka YJ; Belmaker RH; Jacka F; Pariante C; Berk M; Marx W; Su KP
Psychother Psychosom; 2019; 88(5):263-273. PubMed ID: 31480057
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients.
Su KP; Yang HT; Chang JP; Shih YH; Guu TW; Kumaran SS; Gałecki P; Walczewska A; Pariante CM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):227-233. PubMed ID: 28648567
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
[TBL] [Abstract][Full Text] [Related]
6. Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder.
Cussotto S; Delgado I; Oriolo G; Kemper J; Begarie D; Dexpert S; Sauvant J; Leboyer M; Aouizerate B; Martin-Santos R; Schaefer M; Capuron L
Depress Anxiety; 2022 May; 39(5):407-418. PubMed ID: 35357051
[TBL] [Abstract][Full Text] [Related]
7. The mothers, Omega-3 and mental health study.
Mozurkewich E; Chilimigras J; Klemens C; Keeton K; Allbaugh L; Hamilton S; Berman D; Vazquez D; Marcus S; Djuric Z; Vahratian A
BMC Pregnancy Childbirth; 2011 Jun; 11():46. PubMed ID: 21696635
[TBL] [Abstract][Full Text] [Related]
8. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.
Kalkman HO; Hersberger M; Walitza S; Berger GE
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922396
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids for inflamed depression - A match/mismatch study.
Suneson K; Söderberg Veibäck G; Lindahl J; Tjernberg J; Ståhl D; Ventorp S; Ängeby F; Lundblad K; Wolkowitz OM; Lindqvist D
Brain Behav Immun; 2024 May; 118():192-201. PubMed ID: 38432599
[TBL] [Abstract][Full Text] [Related]
10. Polyunsaturated fatty acids and inflammatory markers in major depressive episodes during pregnancy.
Chang JP; Lin CY; Lin PY; Shih YH; Chiu TH; Ho M; Yang HT; Huang SY; Gałecki P; Su KP
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):273-278. PubMed ID: 28536068
[TBL] [Abstract][Full Text] [Related]
11. A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder.
Guu TW; Mischoulon D; Sarris J; Hibbeln J; McNamara RK; Hamazaki K; Freeman MP; Maes M; Matsuoka YJ; Belmaker RH; Marx W; Pariante C; Berk M; Jacka F; Su KP
J Affect Disord; 2020 Mar; 265():233-238. PubMed ID: 32090746
[TBL] [Abstract][Full Text] [Related]
12. Plasma phospholipid n-3 polyunsaturated fatty acids and major depressive disorder in Japanese elderly: the Japan Public Health Center-based Prospective Study.
Hamazaki K; Matsuoka YJ; Yamaji T; Sawada N; Mimura M; Nozaki S; Shikimoto R; Tsugane S
Sci Rep; 2021 Feb; 11(1):4003. PubMed ID: 33597590
[TBL] [Abstract][Full Text] [Related]
13. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial.
Su KP; Lai HC; Yang HT; Su WP; Peng CY; Chang JP; Chang HC; Pariante CM
Biol Psychiatry; 2014 Oct; 76(7):559-66. PubMed ID: 24602409
[TBL] [Abstract][Full Text] [Related]
15. Clinical Efficacy and Biological Regulations of ω-3 PUFA-Derived Endocannabinoids in Major Depressive Disorder.
Yang B; Lin L; Bazinet RP; Chien YC; Chang JP; Satyanarayanan SK; Su H; Su KP
Psychother Psychosom; 2019; 88(4):215-224. PubMed ID: 31269506
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
Kelaiditis CF; Gibson EL; Dyall SC
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
[TBL] [Abstract][Full Text] [Related]
17. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
[TBL] [Abstract][Full Text] [Related]
18. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'?
Su KP
Neurosignals; 2009; 17(2):144-52. PubMed ID: 19190401
[TBL] [Abstract][Full Text] [Related]
19. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
20. Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents.
Chang JP; Su KP
Clin Psychopharmacol Neurosci; 2020 Nov; 18(4):469-483. PubMed ID: 33124582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
